Study of the Safety and Toxicokinetic Parameters of the Drug Eladis® in Preclinical Trials with Repeated Administration

Study of the Safety and Toxicokinetic Parameters of the Drug Eladis® in Preclinical Trials with Repeated Administration

Cough is one of the most common reasons for initial visits to healthcare providers, affecting 40–50% of patients with viral respiratory tract infections. Treatment options for cough include medications that block signal transmission at the central or peripheral level of the reflex arc, as well as mu...

Full description

Saved in:
Bibliographic Details
Main Authors: A. A. Matichin, M. V. Miroshnikov, A. A. Matichina, V. M. Kosman, M. V. Karlina, E. M. Petrova, A. A. Globenko, E. A. Jain, A. V. Kapashin, A. L. Vladykin, A. S. Kolosov, M. A. Pasko
Format: Article
Language:Russian
Published: LLC "Publishing House OKI" 2025-04-01
Series:Антибиотики и Химиотерапия
Subjects:
cough
eladis®
safety
toxicity
toxicokinetics
Online Access:https://www.antibiotics-chemotherapy.ru/jour/article/view/1204
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items